SEC Form 4 · accession 0000899243-17-006344
LANXESS Solutions US Inc. · CHMT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alan M Swiech
Officer — See remarks
Period of report
Mar 1, 2017
Accepted (ET)
Mar 3, 2017 · 4:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001091862
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 1, 2017 | A | 8,283 | $0.00 | A | 103,165 | D | |
| Common Stock | Mar 1, 2017 | F | 3,986 | $33.20 | D | 99,179 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Performance SharesF2 | — | Mar 1, 2017 | A | 8,283 | A | — | Mar 1, 2020 | Common Stock | 8,283 | 8,283 | D |
Explanation of responses
- F1Grant of restricted stock units. The restricted stock units vest in three equal installments: March 1, 2018; March 1, 2019; and March 1, 2020.
- F2Grant of performance shares. Each performance share represents a contingent right to receive between 0 and 2 shares of Chemtura Corporation common stock. The number of shares reported represents the target amount. The actual number of shares to be delivered will be based on Chemtura Corporation's total shareholder return over the three-year vesting period relative to all companies in the Dow Jones US Chemical Index and could equal 200% of the target amount. The performance shares will settle as soon as practicable after December 31, 2019 but no later than March 1, 2020.
Remarks
EVP, Organometallics Specialties & Support Services